Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1989 of 6351
-
Can a dental floss loop make polyp removal faster?
Disease control CompletedPatients scheduled for an endoscopic submucosal dissection(ESD) in the colorectum will be randomized to the use of a traction device(consisting of an endoscopic clip with a loop of dental floss secured in the lesion to be removed, another clip will anchor the loop to adjacent bow…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Trusted adults may keep At-Risk teens off opioids
Prevention CompletedAcross the US, substance use is a significant public health concern, with juvenile justice (JJ)-involved youth representing a particularly vulnerable population. The current study proposes to adapt and test an intervention Trust-based Relational Intervention® (TBRI®) for preventi…
Sponsor: Texas Christian University • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Could a zapping device boost arm recovery in spinal injury?
Symptom relief OngoingTexas Biomedical Device Center at UT Dallas has developed an innovative strategy to enhance recovery of motor and sensory function after neurological injury termed targeted plasticity therapy (TPT). This technique uses brief pulses of vagus nerve stimulation to engage pro-plastic…
Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Fitness test could guide safer stem cell transplants for seniors
Disease control OngoingThis study will evaluate whether a geriatric assessment can lead to better treatment outcomes in older patients (age 60+) with a myeloid malignancy including acute myeloid leukemia, ,myelodysplastic syndromes, myeloproliferative neoplasms, or related blood disorders who are going…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Hospital hep c treatment aims to cure drug users
Disease control Stopped earlyThis study will evaluate the proportion of patients achieving confirmed SVR12 (undetectable HCV RNA at time point 12 weeks plus post treatment commencement) in patients hospitalised for IRID (injecting related infectious diseases) and commencing inpatient DAA treatment within pub…
Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a 12-week virtual program get latina girls moving more?
Disease control CompletedRegular physical activity (PA) contributes to reduced risk of obesity, chronic disease, cardiovascular disease, and cancer, and can improve emotional and mental health, learning, productivity, and social skills. Latina girls are less likely to meet guidelines for moderate-to-vigo…
Sponsor: San Diego State University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Breastfeeding boost: betaine supplement may curb baby obesity risk
Prevention OngoingDeveloping more efficient and cost-effective prevention strategies to slow down the worldwide epidemic of obesity and chronic metabolic disease has become a public health imperative. Our previous results in humans demonstrate that lower breast milk betaine levels were associated …
Phase 1/2 • Sponsor: Fundació Sant Joan de Déu • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New program helps minority seniors fight depression and stay mobile
Disease control CompletedThis study aims to address treatment and service disparities and prevent disability among racial/ethnic and linguistic minority elders. It tests the effectiveness and implementation readiness of the Positive Minds-Strong Bodies Enhanced intervention (PMSB-E), a combined mental an…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy aims to save rectums from surgery
Disease control Recruiting nowThis phase I trial investigates how well short-course radiation therapy followed by combination chemotherapy works in treating patients with stage II-III rectal cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as le…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Personalized muscle training may ease leg pain from blocked arteries
Symptom relief Recruiting nowThe prevalence of peripheral arterial disease is 12.2% in France. Intermittent claudication is the most common symtom of this disease. During physical exercise, such as walking, blood oxygen (O2) requirements increase. The development of atherosclerosis in the lower limbs, causes…
Sponsor: Centre Hospitalier le Mans • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Will shedding pounds heal the pancreas? MRI scans seek answers
Knowledge-focused CompletedThe investigators propose an exploratory study aiming at assessing the impact of surgical bariatric treatment on the improvement of pancreatic lesions detected by MRI. Pancreatic MRI will be performed in severe-obese patients with a planned bariatric surgery, before and 6 months…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Promising antibody drug takes on hard-to-treat bone marrow cancer
Disease control OngoingThis phase II trial investigates how well elotuzumab works in treating patients with JAK2-mutated myelofibrosis. Elotuzumab may help to control myelofibrosis and/or help to improve blood cell count and bone marrow function.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Nanoparticles could supercharge radiation against returning lung tumors
Disease control OngoingThis phase I trial investigates the best dose and side effects of NBTXR3 when given together with radiation therapy for the treatment of non-small cell lung cancer that cannot be treated by surgery (inoperable) and has come back (recurrent). NBTXR3 is a radio-enhancer designed to…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New Pain-Free stimulator offers hope for chronic sufferers
Symptom relief OngoingStudy to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Sep 09, 2026 23:00 UTC
-
New school program aims to get kids with asthma moving more
Disease control CompletedPhysical activity (PA) is an important component of asthma management in children. Studies show that PA is associated with decreased severity of asthma symptoms, as well as improved disease control and quality of life. However, urban minority children with asthma face barriers to…
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Growth hormone trial aims to boost muscle in Prader-Willi patients
Disease control CompletedThis is a multicenter, open label, multi cohort study to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with PWS.
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New program aims to help young men stay out of prison after release
Disease control CompletedThe investigators are conducting a randomized controlled trial to assess the impact of Resiliency in Stressful Experiences (RISE) - a comprehensive trauma-based program for young men releasing from a southeastern state's prisons. The investigators are assessing whether treating t…
Sponsor: Florida State University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a common blood pressure drug slow type 1 diabetes?
Disease control CompletedThis study has been set up within the framework of the INNODIA network. INNODIA is a global partnership between 31 academic institutions, 6 industrial partners, a small sized enterprise and 2 patient organizations, bringing their knowledge and experience together with one common …
Phase 2 • Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a simple pill shield transplant patients from deadly fungal infections?
Prevention CompletedThis open, prospective, observational multicenter cohort study aims to evaluate the efficacy, safety as well as the effective serum concentration of Posaconazole for prevention of pulmonary fungal infections in patients with hematopoietic stem cell transplantation. The correlatio…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Electric heart boost: new device shows promise for failing hearts
Disease control CompletedPatients with idiopathic dilative cardiomyopathy who have systolic left ventricular dysfunction (NYHA III - IV) despite adequate therapy according to treatment guidelines of heart failure and who have a baseline left ventricular ejection fraction of ≥25% and ≤35 will receive a C-…
Sponsor: Berlin Heals GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC